Items where authors include "Isaacs, J.D."

Article

Rekowski, J. orcid.org/0000-0002-5207-3864, Guo, C., Solovyeva, O. et al. (35 more authors) (2025) CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials. eClinicalMedicine, 79. 102987. ISSN 2589-5370

Ursino, M., Villacampa, G., Rekowski, J. orcid.org/0000-0002-5207-3864 et al. (34 more authors) (2025) SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols. eClinicalMedicine, 79. 102988. ISSN 2589-5370

Ling, S.F. orcid.org/0000-0001-8148-2344, Ogungbenro, K., Darwich, A.S. orcid.org/0000-0001-8218-4306 et al. (9 more authors) (2024) Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis. Pharmaceutics, 16 (6). 702. ISSN 1999-4923

Brown, P.M. orcid.org/0000-0002-3271-3596, Anderson, A.E., Naamane, N. et al. (4 more authors) (2024) Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis. RMD Open, 10 (1). ARTN e003858. ISSN 2056-5933

Yap, C.F. orcid.org/0000-0001-5256-5642, Nair, N., de Vries, A. et al. (7 more authors) (2024) HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 83 (2). pp. 263-265. ISSN 0003-4967

Chatzigeorgiou, C. orcid.org/0000-0003-1471-025X, Barrett, J.H., Martin, J. et al. (53 more authors) (2023) Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association study. Rheumatology. kead643. ISSN 1462-0324

Maunder, D., Brown, P.M., Barron-Millar, B. et al. (10 more authors) (2023) Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacy. Rheumatology. kead569. ISSN 1462-0324

Curry, P.D.K. orcid.org/0000-0003-0013-460X, Chinoy, H. orcid.org/0000-0001-6492-1288, Jani, M. orcid.org/0000-0002-1487-277X et al. (8 more authors) (2023) The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort. The Journal of Rheumatology, 50 (11). pp. 1518-1521. ISSN 0315-162X

Yap, C. orcid.org/0000-0002-6715-2514, Solovyeva, O. orcid.org/0000-0001-7828-4099, de Bono, J. orcid.org/0000-0002-2034-595X et al. (32 more authors) (2023) Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT dose-finding extension (CONSORT-DEFINE) guidance. BMJ, 383. e076387. ISSN 0959-8138

Ling, S.F. orcid.org/0000-0001-8148-2344, Yap, C.F., Nair, N. orcid.org/0000-0001-9829-792X et al. (7 more authors) (2023) A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures. Rheumatology. kead321. ISSN 1462-0324

Ball, H.A., McWhirter, L., Ballard, C. et al. (20 more authors) (2021) Reply : Functional cognitive disorder : dementia's blind spot. Brain, 144 (9). e73. ISSN 0006-8950

Cole, M., Yap, C., Buckley, C. et al. (7 more authors) (2021) TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis. Trials, 22. 433. ISSN 1468-6708

Ball, H.A., McWhirter, L., Ballard, C. et al. (22 more authors) (2020) Functional cognitive disorder : dementia’s blind spot. Brain, 143 (10). pp. 2895-2903. ISSN 0006-8950

Jani, M., Isaacs, J.D., Morgan, A.W. et al. (5 more authors) (2016) High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. Annals of the Rheumatic Diseases. annrheumdis-2015. ISSN 0003-4967

Cui, J., Stahl, E.A., Saevarsdottir, S. et al. (53 more authors) (2013) Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis. PLOS Genetics, 9 (3). e1003394. ISSN 1553-7404

Morgan, A.W., Barrett, J.H., Griffiths, B. et al. (12 more authors) (2005) Analysis of Fcγ receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Research and Therarpy, 8 (R5). ISSN 1478-6362

Mackie, S., Robinson, J.I., Barrett, J.H. et al. (12 more authors) (2005) Association of FCGR3A and FCGR3B haplotypes with rheumatoid arthritis and primary Sjögren's syndrome [POSTER PRESENTATION]. Arthritis Research and Therapy, 7 (Suppl ). p. 121. ISSN 1478-6362

Ponchel, F., Verburg, R.J., Bingham, S.J. et al. (24 more authors) (2004) Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Research and Therapy, 7 (1). R80-R92. ISSN 1478-6362

Ponchel, F., Verburg, R.J., Bingham, S.J. et al. (24 more authors) (2004) Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Research & Therapy, 7 (1). R80-R92. ISSN 1478-6354

Ponchel, F., Toomes, C., Bransfield, K. et al. (11 more authors) (2003) Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnology, 3 (18). ISSN 1472-6750